New Market Study, "Menjugate (Meningococcal Vaccines) - Forecast and Market Analysis to 2022", Has Been Published
Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset and severity of symptoms makes prompt and effective diagnosis and treatment nearly impossible. For these reasons the meningococcal disease space is dominated by vaccines.
View full press release